EUCTR2013-004969-14-FI进行中（未招募）不适用
Measurement of levels of infliximab and anti-infliximab antibodies inrheumatic patients
Heidi Mäkinen0 个研究点目标入组 150 人开始时间: 2014年1月15日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with infliximab therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's ColitisInflammatory Bowel Diseases10017969NL-OMON37225Academisch Medisch Centrum12
进行中（未招募）
1 期
se of combined measurements of serum infliximab and anti-infliximab antibodies in the treatment of patients with Crohns disease failing infliximab therapyPatients with Crohns diseases failing treatment with infliximabMedDRA version: 13.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2009-009926-94-DKDepartment of medical gastroenterology, Herlev Hospital
已完成
不适用
Comparison between venous infliximab blood level and bloodspot-technology in children with inflammatory bowel disease.chronic inflammation of the bowelInflammatory bowel disease10017969NL-OMON45579Erasmus MC, Universitair Medisch Centrum Rotterdam20
已完成
3 期
Efficacy of Infliximab comparing with Cyclophosphamide in refractory uveitis in Behcet’s diseasesBehcet's diseaseIRCT20180110038297N1Zanjan University of Medical Sciences20
Unknown
不适用
Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in SerumInflammatory Bowel DiseasesNCT03308357The Alfred6